Skin conditions are the fourth leading cause of nonfatal disease burden worldwide, and fungal skin disease is the most prevalent category within them, with more than 2 billion cases recorded globally. Fungal infections account for around a third of new skin disorder cases.
65 topical presentations across cream, ointment, gel, spray, solution and shampoo formats, weighted to antifungal and corticosteroid combinations.
Range depth
5 betamethasone presentations.
Ointment and shampoo presentations.
Gel, spray and solution formats.
We establish what is already registered in your market, who supplies it today, and where demand is going unmet.
We set your current range against the portfolio and separate genuine gaps from lines you already stock.
You get the molecules in filing order, which of them need a dossier built for your authority, and which fall outside the range.
We compile the dossier in CTD format for your authority and supply the COPP and plant-level WHO-GMP and PIC/S certificates behind it.
We analyse your market and set your existing range against the portfolio, then return the molecules worth filing in priority order with the documentation route for each.